The disease caused by the SARS-CoV-2 coronavirus (COVID-19) has affected millions of people worldwide. The first cases of atypical pneumonia that turned out to be caused by SARS-CoV-2 were reported in December 2019 in the city of Wuhan in the Hubei province in China. The World Health Organization eventually declared the outbreak a public health emergency of international importance (ESPII) on 30 January 2020 and on 11 March of that same year, COVID-19 was declared a pandemic. Despite all the advances achieved since that time, there are still no specific treatments for the management of the disease.
The severity of COVID-19 and its impact on society led to an unprecedented effort towards the development and subsequent distribution of vaccines against the disease. At the present time, vaccination is probably the most effective strategy to control COVID-19 and prevent it in the future, and therefore represents a fundamental strategy that should be closely monitored and evaluated1,2. Vaccination programmes against SARS-CoV-2 are tools that will help reduce both the number of cases, as well as the number of hospitalisations and deaths associated with the infection. Thus, the hope is that they will help facilitate the restoration of the normal functioning of society, which has suffered huge human costs and economic consequences as a result of the pandemic.
In Spain, the main objective of the vaccination strategy against COVID-19 is to reduce the morbidity and mortality of the disease. In addition, the progress of the programme is being modified as different vaccines are authorised and received, our scientific knowledge is expanding, and the context of the pandemic is changing3. However, despite the obvious impact on human health, the economy, and people’s lifestyles, several studies have shown that acceptance of the vaccine to prevent SARS-CoV-2 infection will not be universal. During the H1N1 pandemic, which had a lesser impact than that of COVID-19, the vaccine acceptance rate was also low. The main reasons cited for this were fear of adverse events associated with a new vaccine, distrust of the vaccine and the authorities administering it, and an underestimation of the risk of becoming infected with the H1N1 flu virus.
Therefore, it seems that, despite its strong impact on the functioning of our societies, acceptance of a vaccine to prevent SARS-CoV-2 will also not be automatic4. While vaccination is widely recognised by health authorities and the medical community as an effective measure to reduce or eliminate the burden of infectious diseases, its effectiveness also depends on the willingness of individuals to be vaccinated. Moreover, the receptiveness of the population towards vaccines could be negatively affected by their doubts and concerns about their safety and suitability1.
As we previously noted, despite the enormous efforts and progress made in addressing COVID-19 since the beginning of the pandemic, little attention has been devoted to another important aspect of the crisis: understanding and assessing the perception of the care received by patients who have had the disease. The work published in March 2021 by Meng-San Wu showed the results of a satisfaction survey completed by patients hospitalised for COVID-19 in Liverpool in the United Kingdom. Users gave a high rating to the quality of care received, particularly from medical and nursing staff, with communication being the area for improvement most often recommended by those surveyed5,6.
Limited information is available regarding the perceptions and beliefs of people who have recovered from COVID-19 in relation to the care they received during the healthcare process. Therefore, a better understanding of these attitudes remains crucial because they could contribute to both the design and implementation of future interventions related to COVID-19. Sadly, this fact appears to have been overlooked by the scientific community during the pandemic, because little attention has been paid to these perspectives.
To improve future vaccination strategies and help achieve greater vaccination coverage we must assess the satisfaction perceived by users at different points during the vaccination process. This will allow areas of deficit to be identified and worked upon to promote improvement measures and achieve higher quality care. Despite the fact that many studies have analysed the reasons that determine the decision to get vaccinated, fewer have analysed the perception or satisfaction of users towards the vaccination process itself7,8. Moreover, to the best of our knowledge, no studies have evaluated patient satisfaction with current COVID-19 vaccination programmes.
Given that the perception of users towards the quality of the care process is related to the characteristics of each patient, satisfaction must be assessed not only globally, but also specifically in subpopulations with certain characteristics. In the case of Spain, vaccination against COVID-19 is being carried out in a staggered manner according to priority. The programme started in March 2021 with the vaccination of Group 6 comprising teaching and non-teaching staff working in early childhood, special-needs, primary, and secondary education.
In this study we carried out the first patient satisfaction survey completed by a specific population group (educational centre staff) regarding the COVID-19 vaccination programme. Thus, our objective was to determine the level of satisfaction of these staff with the COVID-19 vaccination programme carried out at the facilities of the General University Hospital of Alicante in Spain.